Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sean Janzer

Interventional Cardiology York, PA Medical Doctor

NPI 1518962331 CMS profile 341414

30 Monument Rd Ste 1100, York, PA 17403

Open in the dashboard

General payments

$205,152

539 records reported · program years 2019–2025

Research payments

$500

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$73,102 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Sean Janzer of York, PA is reported in the CMS Open Payments database as having received $205,152 across 539 general payments and $500 in research payments paid to them. Separately, studies naming them as principal investigator received $73,102 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,588 30
2024 General $44,171 65
2023 General $10,666 47
2022 General $18,038 67
2021 General $35,521 69
2020 General $15,029 65
2020 Research $500 1
2019 General $65,139 196

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sean Janzer
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Sean Janzer were reported at $16,588. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Sean Janzer Interventional Cardiology median Middle half National median
2019 $65,139 $1,097 $329–$3,048 $163
2020 $15,029 $473 $161–$1,480 $114
2021 $35,521 $677 $233–$1,827 $132
2022 $18,038 $978 $333–$2,724 $149
2023 $10,666 $1,136 $382–$2,986 $160
2024 $44,171 $1,181 $395–$3,326 $164
2025 $16,588 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Abbott Laboratories $68,373 121 payments
  2. Boston Scientific Corporation $68,189 157 payments
  3. Cardiovascular Systems Inc. $16,923 42 payments
  4. Avinger Inc. $16,785 55 payments
  5. Philips Electronics North America Corporation $15,349 27 payments
  6. Siemens Medical Solutions USA, Inc. $5,889 12 payments
  7. Medtronic Vascular, Inc. $3,434 14 payments
  8. Cagent Vascular LLC $2,100 2 payments
  9. Medtronic, Inc. $2,093 20 payments
  10. Abiomed $2,070 17 payments
  11. Other $3,948 72 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $74,900 20 payments
  2. Consulting Fee $52,413 36 payments
  3. Travel and Lodging $37,570 116 payments
  4. Food and Beverage $16,094 357 payments
  5. Compensation for serving as faculty or as a speaker for a medical education program $12,375 4 payments
  6. Honoraria $9,538 3 payments
  7. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,175 2 payments
  8. Education $89 1 payment
Products named General payments · program years 2019–2025
  1. Diamondback Coronary Vascular $36,188 55 payments
  2. CROSSBOSS $29,570 21 payments
  3. OPTIS $25,276 28 payments
  4. GENERAL VASCULAR ACCESS $23,523 15 payments
  5. Spectranetics Undiv $13,648 6 payments
  6. PANTHERIS Vascular $10,506 15 payments
  7. Diamondback Peripheral $7,968 11 payments
  8. PANTHERIS Vascular $6,279 40 payments
  9. Diamondback Coronary Atherectomy Device $6,027 8 payments
  10. Xience V coronary stent system $6,019 11 payments
  11. Other $35,505 328 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Philips Electronics North America Corporation $500 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Interventional Cardiology: 2,236

Drug cost

$13

Median for Interventional Cardiology: $380,412

Branded share of claims

0%

Median for Interventional Cardiology: 27.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Atenolol Generic 11 $13

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 4,694 Part D prescribers listed as Interventional Cardiology; they describe a distribution and say nothing about conduct.

Records

540 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record